Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3

J. Reinsberg; Birgit Gast; J. Schmolling; U. Wagner; D. Krebs

doi:10.1515/cclm.1994.32.9.691

Home Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3

Article

Licensed

Unlicensed Requires Authentication

Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3

J. Reinsberg , Birgit Gast , J. Schmolling , U. Wagner and D. Krebs

Published/Copyright: September 16, 2009

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

Clinical Chemistry and Laboratory Medicine (CCLM)

From the journal Volume 32 Issue 9

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Reinsberg, J., Gast, Birgit, Schmolling, J., Wagner, U. and Krebs, D.. "Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3" Clinical Chemistry and Laboratory Medicine (CCLM), vol. 32, no. 9, 1994, pp. 691-696. https://doi.org/10.1515/cclm.1994.32.9.691

Reinsberg, J., Gast, B., Schmolling, J., Wagner, U. & Krebs, D. (1994). Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3. Clinical Chemistry and Laboratory Medicine (CCLM), 32(9), 691-696. https://doi.org/10.1515/cclm.1994.32.9.691

Reinsberg, J., Gast, B., Schmolling, J., Wagner, U. and Krebs, D. (1994) Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3. Clinical Chemistry and Laboratory Medicine (CCLM), Vol. 32 (Issue 9), pp. 691-696. https://doi.org/10.1515/cclm.1994.32.9.691

Reinsberg, J., Gast, Birgit, Schmolling, J., Wagner, U. and Krebs, D.. "Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3" Clinical Chemistry and Laboratory Medicine (CCLM) 32, no. 9 (1994): 691-696. https://doi.org/10.1515/cclm.1994.32.9.691

Reinsberg J, Gast B, Schmolling J, Wagner U, Krebs D. Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3. Clinical Chemistry and Laboratory Medicine (CCLM). 1994;32(9): 691-696. https://doi.org/10.1515/cclm.1994.32.9.691

Copy

Copied to clipboard

BibTeX EndNote RIS

Online erschienen: 2009-09-16

Erschienen im Druck: 1994

Walter de Gruyter

You are currently not able to access this content.

Articles in the same Issue

Titelei
Sonstiges
Lysosomes and Human Liver Disease: A Biochemical and Immunohistochemical Study of -Hexosaminidase
Posttranslational Heterogeneity of Bone Alkaline Phosphatase in Metabolic Bone Disease
Coagulation Factor XIII in Plasma of Patients with Benign and Malignant Gynaecological Tumours
Neopterin Production and Tryptophan Degradation in Acute Lyme Neuroborreliosis Versus Late Lyme Encephalopathy
Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3
Expression of the erb B Oncogene in the Morris Hepatoma 7777
Measurement of Salivary Insulin-Like Growth Factor-I in Acromegaly: Comparison with Serum Insulin-Like Growth Factor-I and Growth Hormone Concentrations
A Manual Spectrophotometric Method for the Measurement of Serum Sodium and Potassium by Enzyme Activation
SHORT COMMUNICATION
TECHNICAL NOTE

Search journal Search the content of this journal

https://doi.org/10.1515/cclm.1994.32.9.691

Articles in the same Issue

Titelei
Sonstiges
Lysosomes and Human Liver Disease: A Biochemical and Immunohistochemical Study of -Hexosaminidase
Posttranslational Heterogeneity of Bone Alkaline Phosphatase in Metabolic Bone Disease
Coagulation Factor XIII in Plasma of Patients with Benign and Malignant Gynaecological Tumours
Neopterin Production and Tryptophan Degradation in Acute Lyme Neuroborreliosis Versus Late Lyme Encephalopathy
Specific Interference with the Determination of the Tumour-Associated Glycoprotein 72 by Human Anti-Idiotypic Antibodies Formed after Treatment with the Anti-Tumour-Associated Glycoprotein 72 Antibody B72.3
Expression of the erb B Oncogene in the Morris Hepatoma 7777
Measurement of Salivary Insulin-Like Growth Factor-I in Acromegaly: Comparison with Serum Insulin-Like Growth Factor-I and Growth Hormone Concentrations
A Manual Spectrophotometric Method for the Measurement of Serum Sodium and Potassium by Enzyme Activation
SHORT COMMUNICATION
TECHNICAL NOTE